Filing Details
- Accession Number:
- 0001181431-12-015158
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-03-07 16:06:57
- Reporting Period:
- 2012-03-05
- Filing Date:
- 2012-03-07
- Accepted Time:
- 2012-03-07 16:06:57
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1400431 | Patheon Inc | PTI | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1226288 | C James Mullen | 4721 Emperor Blvd Suite 200 Durham NC 27703 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Restricted Voting Shares | Acquisiton | 2012-03-05 | 9,500 | $1.73 | 983,785 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 12, 2012.
- The amounts reported in column 4 and this footnote (2) were converted from Canadian dollars into U.S. dollars based on the March 5, 2012 closing exchange rate of 0.9943 Canadian dollars per U.S. dollar as quoted by Reuters.